Plaque Psoriasis Treatment Market - 2024

December 2025 | 219 pages | ID: PF5C4DD9B77EEN
DataM Intelligence

Abstracts

The Plaque Psoriasis Treatment Market was valued at USD 12.7 billion in 2024 and is anticipated to reach by , at a CAGR of 0.0889 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Plaque Psoriasis Treatment Market.

This report delivers a comprehensive overview of the Plaque Psoriasis Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plaque Psoriasis Treatment Market. The Plaque Psoriasis Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–.

Plaque Psoriasis Treatment Market Scope:

By Disease Type

• Small-Plaque Psoriasis
• Large-Plaque Psoriasis
• Unstable Plaque Psoriasis
• Chronic Plaque Psoriasis

By Treatment Type

• Topical Medications
• Systemic Drugs
• Biologics
• Phototherapy
• Others

By Sales Channel

• Distribution Channel
• End-User

Key Players

• Dermavant Sciences, Inc.
• Novartis AG
• Pfizer Inc.
• Mylan N.V.
• Boehringer Ingelheim Pharmaceuticals, Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• Lupin Pharmaceuticals, Inc.
• AbbVie Inc.
• Eli Lilly and Company

Major Highlights

This report delivers a comprehensive overview of the Plaque Psoriasis Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plaque Psoriasis Treatment Market. The Plaque Psoriasis Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Disease Type
3.2. Snippet by Treatment Type
3.3. Snippet by Sales Channel
3.4. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing Adoption of Innovative Medications
  4.1.2. Restraints
    4.1.2.1. Side Effects Associated with the Use of Corticosteroids
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. Patent Analysis
5.8. Volume Analysis
5.9. DMI Opinion

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID
  6.1.2. Scenario During COVID
  6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY DISEASE TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  7.1.2. Market Attractiveness Index, By Disease Type
7.2. Small-Plaque Psoriasis*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Large-Plaque Psoriasis
7.4. Unstable Plaque Psoriasis
7.5. Chronic Plaque Psoriasis

8. BY TREATMENT TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  8.1.2. Market Attractiveness Index, By Treatment Type
8.2. Topical Medications*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  8.2.3. Anthralin
  8.2.4. Roflumilast (Zoryve)
  8.2.5. Corticosteroids
  8.2.6. Tapinarof (Vtama)
  8.2.7. Salicylic Acid
  8.2.8. Coal Tar
  8.2.9. Zinc Pyrithione
  8.2.10. Topical Emollients
  8.2.11. Others
8.3. Systemic Drugs
  8.3.1. Acitretin
  8.3.2. Cyclosporine
  8.3.3. Methotrexate
8.4. Biologics
  8.4.1. Adalimumab (Humira)
  8.4.2. Brodalumab (Siliq)
  8.4.3. Certolizumab-Pegol (Cimzia)
  8.4.4. Deucravacitinib (Sotyktu)
  8.4.5. Etanercept (Enbrel)
  8.4.6. Guselkumab (Tremfya)
  8.4.7. Infliximab (Avsola, Inflectra, Remicade)
  8.4.8. Others
8.5. Phototherapy
  8.5.1. Exposure To UVB Light
  8.5.2. Psoralen Plus Ultraviolet A (PUVA)
  8.5.3. Excimer Laser Therapy
  8.5.4. Home Phototherapy
  8.5.5. Others
8.6. Others

9. BY SALES CHANNEL

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  9.1.2. Market Attractiveness Index, By Sales Channel
9.2. Distribution Channel*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  9.2.3. Hospital Pharmacies
  9.2.4. Retail Pharmacies
  9.2.5. Online Pharmacies
9.3. End-User
  9.3.1. Hospitals
  9.3.2. Dermatology Clinics
  9.3.3. Phototherapy Centers
  9.3.4. Others

10. BY REGION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.6.1. U.S.
    10.2.6.2. Canada
    10.2.6.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.6.1. Germany
    10.3.6.2. UK
    10.3.6.3. France
    10.3.6.4. Italy
    10.3.6.5. Spain
    10.3.6.6. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.6.1. Brazil
    10.4.6.2. Argentina
    10.4.6.3. Rest of South America
10.5. Asia-Pacific
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.5.6.1. China
    10.5.6.2. India
    10.5.6.3. Japan
    10.5.6.4. Australia
    10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

11. COMPETITIVE LANDSCAPE

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. COMPANY PROFILES

12.1. Dermavant Sciences, Inc.*
  12.1.1. Company Overview
  12.1.2. Product Portfolio and Description
  12.1.3. Financial Overview
  12.1.4. Key Developments
12.2. Novartis AG
12.3. Pfizer Inc.
12.4. Mylan N.V.
12.5. Boehringer Ingelheim Pharmaceuticals, Inc.
12.6. AstraZeneca PLC
12.7. Bristol-Myers Squibb Company
12.8. Lupin Pharmaceuticals, Inc.
12.9. AbbVie Inc.
12.10. Eli Lilly and Company (LIST NOT EXHAUSTIVE)

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us